Skip to main
ZYXI
ZYXI logo

Zynex Inc (ZYXI) Stock Forecast & Price Target

Zynex Inc (ZYXI) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Zynex Inc has demonstrated a robust growth trajectory, with orders growing 16% year-over-year in fiscal year 2024, indicating strong demand for its electrotherapy and pain management products. The company's focus on innovation, highlighted by the positive results from the NiCo verification clinical study, suggests that its advanced laser-based system may outperform existing solutions in the market, further enhancing its competitive edge. Additionally, projected operational cost reductions of approximately $35 million annually and goals to improve revenue per sales representative bolster the company’s financial efficiency and growth potential, underpinning a positive outlook for its stock.

Bears say

Zynex Inc. is facing a significant downward trend in its financial performance, as evidenced by its projected Q1 2025 sales of at least $30 million, indicating a decline of 37% year-over-year and a 35% sequential decrease. The company reported a total revenue of $46 million for Q4 2024, which was a 3% decline from the previous year and fell short of projections by $8 million, with disappointing device sales dropping by 9%. Furthermore, the outlook for 2025 has worsened considerably, with expected sales reduced to $140 million from a prior estimate of $241 million, reflecting a notable lack of visibility into the company's operational health and ongoing business headwinds.

Zynex Inc (ZYXI) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zynex Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zynex Inc (ZYXI) Forecast

Analysts have given Zynex Inc (ZYXI) a Buy based on their latest research and market trends.

According to 6 analysts, Zynex Inc (ZYXI) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zynex Inc (ZYXI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.